Company Profile

SOLARA ACTIVE PHARMA SCIENCE LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE454.5511.4 (+2.57 % )
PREV CLOSE (Rs.) 443.15
OPEN PRICE (Rs.) 441.60
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 495
TODAY'S LOW / HIGH (Rs.)437.40 456.45
52 WK LOW / HIGH (Rs.)275.1 737
NSE453.15 8.6 (+1.93 % )
PREV CLOSE(Rs.) 444.55
OPEN PRICE (Rs.) 439.70
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 10835
TODAY'S LOW / HIGH(Rs.) 431.20 456.00
52 WK LOW / HIGH (Rs.)273 725.1

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 2.22673
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 4.46
ROCE (%) 9.93
Incorporation Year : 2017

Management Info :

Deepak Vaidya - Chairman Jitesh Devendra - Managing Director

Registered Office :

Address : 201, Devavrata,Sector 17,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone : 022 2789 2924

Website : www.solara.co.in

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
16Mar03-16-2020$Solara Active Pharma Sciences submits clarification Solara Active Pharma Science

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Solara Active Pharma Sciences has submitted a copy of clarification. 

The above information is a part of company’s filings submitted to BSE.

With reference to significant movement in price, in order to en..
24Feb02-24-2020$USFDA completes inspections at Solara Active Pharma's Puducherry, Mangalore facility USFDA completes inspections

United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

United States Food and Drug Administration (USFDA) has complete..
24Feb02-24-2020$Solara Active Pharma Sciences zooms on bourses Solara Active Pharma Science

Solara Active Pharma Sciences is currently trading at Rs. 715.25, up by 35.00 points or 5.15% from its previous closing of Rs. 680.25 on the BSE.

The scrip opened at Rs. 688.90 and has touched a high and low of Rs. 737.00 and Rs. 688.90 respectively. So far 17424 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 737.00 on 24-Feb-2020 and a 52 week low of Rs. 275.10 on 05-Aug-2019.

Last one week high and low of the scrip stood at Rs. 737.00 and Rs. 601.00 respectively. The current market cap of the company is Rs. 1859.82 crore.

The promoters holding in the company stood at 40.14%, while Institutions and Non-Institutions held 23.36% and 36.51% respectively.

United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Sciences is currently trading at Rs. 715.2..
24Feb02-24-2020$ Announcement under Regulation 30 (LODR)-Press Release / Media Release Announcement under Regulati
"Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s"
"Solara Puducherry and Mangalore facilities complete USFDA Insp..
22Feb02-22-2020$Solara Active Pharma Sciences informs about press release Solara Active Pharma Science

Solara Active Pharma Sciences has informed that the company has enclosed a press release issued by the Company titled ‘Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s’.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Sciences has informed that the company has..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit412.1620
Gross Profit 412.1 716.9
Operating Profit 835.42328.4
Net Sales 3436.813672.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 6483.75 (3.87%)
M.Cap ( in Cr)
14932.48
Abbott India (BSE)
 15639.50 (1.19%)
M.Cap ( in Cr)
33232.85
Hester Biosciences (BSE)
 951.70 (2.88%)
M.Cap ( in Cr)
809.60
Procter&Gamble Healt (BSE)
 3669.75 (0.69%)
M.Cap ( in Cr)
6091.56
NGL Fine-Chem (BSE)
 274.45 (8.33%)
M.Cap ( in Cr)
169.56
Shareholding Pattern More
MUTUAL FUNDS/UTI 5.57 %
PROMOTERS 40.14 %
NON-INSTITUTION 36.51 %
FI/BANKS/INSURANCE 0.23 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes